IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q2 2016 Holdings

Filed 2016-08-12 | 22 holdings | $21.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$21.5M3,608,17198.2%
Loxo Oncology IncCOM548862101$93.4K4,028,9200.4%
Zeltiq Aesthetics IncCOM98933Q108$57.7K2,109,7270.3%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$32.4K2,990,0000.1%
Viewray Inc.(VRAYQ)COM92672L107$30.5K7,461,9230.1%
Versartis IncCOM92529L102$25.2K2,279,5680.1%
T2 Biosystems IncCOM89853L104$22.3K2,830,9920.1%
Cempra IncCOM15130J109$19.7K1,193,0600.1%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$19.7K2,583,7970.1%
Cynapsus Therapeutics Inc.COM PAR NO PAR23257Y859$17.1K1,021,3810.1%
Syros Pharmaceuticals, Inc.COM87184Q107$16.5K908,5650.1%
Esperion Therapeutics Inc.(ESPR)COM29664W105$16.2K1,637,1250.1%
Catalent Inc(CTLTEUR)COM148806102$10.9K472,7810.0%
Cidara Therapeutics Inc.COM171757107$10.5K1,021,1480.0%
Transenterix Inc.COM NEW89366M201$10.2K8,335,8190.0%
Paratek Pharmaceuticals IncCOM699374302$6.7K482,6800.0%
Intersect ENT IncCOM46071F103$5.8K450,0000.0%
Dermira Inc(DERMEUR)COM24983L104$3.0K102,5930.0%
Chimerix Inc.(CMRXEUR)COM16934W106$1.9K472,9430.0%
Lombard MED IncCOMG55598109$966886,3630.0%
Pernix Therapeutics Hldgs inCOM71426V108$9052,010,0000.0%
Pernix Therapeutics Hldgs IncDBCV 4.25% 4/071426VAK4$575$2,500,0000.0%